Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance.
about
Targeting the indoleamine 2,3-dioxygenase pathway in cancerGenetic disorders coupled to ROS deficiencyCancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer controlImmunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancerInterleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma.Epstein-Barr virus infection induces indoleamine 2,3-dioxygenase expression in human monocyte-derived macrophages through p38/mitogen-activated protein kinase and NF-κB pathways: impairment in T cell functions.The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma.Molecular characterization of subcutaneous panniculitis-like T-cell lymphoma reveals upregulation of immunosuppression- and autoimmunity-associated genes.Characterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma.Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4.Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer.Progesterone Alters Kynurenine Pathway Activation in IFN-γ-Activated Macrophages - Relevance for Neuroinflammatory Diseases.Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation.Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells.Dendritic cell vaccines: A review of recent developments and their potential pediatric application.Insight on the impacts of free amino acids and their metabolites on the immune system from a perspective of inborn errors of amino acid metabolism.Macrophages, Inflammation, and Lung Cancer.Regulation of indoleamine 2,3-dioxygenase in primary human saphenous vein endothelial cells.A novel immunohistochemical score to predict early mortality in acute myeloid leukemia patients based on indoleamine 2,3 dioxygenase expression.Immunosuppressive mechanisms of regulatory dendritic cells in cancer.Highlights of the society for immunotherapy of cancer (SITC) 27th annual meeting.Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: an early marker of resistance to immune control?Indoleamine 2,3-dioxygenase expression regulates the survival and proliferation of Fusobacterium nucleatum in THP-1-derived macrophages.The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets
P2860
Q26775471-5D81FEBD-DA75-453F-8FAA-CFB3AC8828BDQ26799545-4890B0CF-1E99-4D2A-ACBE-DA45E6F2726FQ26860058-14BC78D7-B989-43C7-93E6-E5E0616B6DB4Q26996829-D3B17193-F0EF-4D0B-8B8B-C6D9E4E72C79Q33565624-E06D2058-B361-4C47-907A-8B79B2AD5CE3Q33743826-D837D417-7830-4835-ADBE-AE3E54D5D990Q33929529-00012307-5B62-4FDD-8380-EEBD8F0FE542Q35059964-E656CEF7-330E-4FA2-8A08-9736F5085D10Q35507112-BFEEABD6-3FB3-4E3A-8EC3-36788111648AQ36973676-FFC559F5-D298-4687-8D64-6369E023C123Q37457684-2665FB6E-589B-4166-B101-EA9F3EE5A8F2Q37489173-10BC9BD2-AA90-42BE-A7E6-CD5EBC4637DEQ37499246-C021A403-4A45-4D0E-9123-91FBABCDE083Q38193589-6B7E4FCA-B634-4B88-B893-8EC37E358C6DQ38849396-11B17F03-048C-4D58-AD5C-67A9C6779242Q39261875-97FD4FA3-2230-4320-8B0B-F29D377B48EFQ41113415-16E73EAA-F924-4DBE-94F8-542B4FB61EB3Q41171963-A96C5EF7-7D16-42E0-B2CB-1A95F1DEE01DQ42379001-226D9C49-B6DC-4A4A-9D13-D0BFAF3213F8Q43084328-FD656423-CCDC-4321-AD25-B42E90ADB39AQ46507832-B0D39D0A-3461-41EB-9326-3BA2A80E52E7Q49071066-F44D1E77-7230-4B24-BE6E-5706337446BBQ51736514-D536E542-C647-49F5-B985-CB49116AEBAEQ58791203-D929FE16-571B-466C-BF17-D80CC8E7E6D7
P2860
Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance.
@en
type
label
Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance.
@en
prefLabel
Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance.
@en
P2860
P1476
Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance
@en
P2093
Theodore S Johnson
P2860
P304
P356
10.3109/08820139.2012.689405
P577
2012-01-01T00:00:00Z